Deva Holding AS | DEVA - Beban Bunga Utang

Harga Saham

67.90

Perubahan Harian

0.95 1.42%

Bulanan

8.12%

Tahunan

18.29%

Q2 Perkiraan

64.45

Keuangan

TRY

TRY 12.93B

TRY 775.92M

Biaya Penjualan

TRY 991.13M

TRY 9.13B

Kewajiban Lancar

TRY 6.43B

TRY 5.3B

Dividen - Hasil

0.18

TRY 820.88M

TRY 882.9M

Eps Laba Per Saham

TRY 2.92

Modal Dan Cadangan

TRY 5.79B

Laba Kotor Pada Penjualan

TRY 1.32B

Beban Bunga Utang

TRY 272.53M

TRY 559.97M

Kapitalisasi Pasar

TRY 13.39B

Batas Pemasukan

TRY 583.98M

Biaya Operasional

TRY 1.35B

Laba Operasional

TRY 964.87M

Modal Saham Biasa

TRY 200.02M

Pe Harga Untuk Laba

6.55

Pendapatan Penjualan

TRY 2.32B

Beban Penjualan Dan Administrasi

TRY 462.26M

Kreditur Perdagangan

TRY 809.81M

Debitur Perdagangan

TRY 3.03B

	Beban Bunga Utang	Perubahan		Tanggal
Akebia Therapeutics	4.83M		359.32M	2025-12
Alaunos Therapeutics	USD 1.07M		215K	2023-06
Avita Medical	AUD 1.25M		100K	2025-06
Deva Holding AS	TRY 272.53M		69.04M	2023-09
Dianthus Therapeutics	USD 4.44M		263K	2024-09
Ionis Pharmaceuticals	USD 18M		0	2025-12
IQVIA Holdings	USD 193M		4M	2025-12
Moderna	USD 12.14B		12.13B	2025-09
Organon & Co	USD 128M		3M	2025-09
Revvity	USD 23.51M		742K	2025-12
Tectonic Therapeutic	USD 12K		276.99M	2025-12
Viatris	USD 119.6M		0	2025-12
Xeris Pharmaceuticals	USD 7.15M		115K	2025-12